PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10043419::ACT000072

MPI-SP

Evidence text

Paper-level observation

OMV^MPI-SP and OMV^MPI-C treatments resulted in better therapeutic outcomes with statistical significance when compared with the PBS group.
figureConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
survival_rate
Comparator
=
Raw observation
better therapeutic outcomes
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Mus musculus
Assay method
Not reported by source
Sequence
Not reported by source
Standardization
insufficient information

Source publication

Bioengineered bacterial outer membrane vesicles encapsulated Polybia–mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy

Frontiers in Immunology · 2023

DOI 10.3389/fimmu.2023.1129771 PMC10043419
Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.